The molecular heterogeneity of the precancerous breast affects drug efficacyAnjana Bhardwaj(The University of Texas MD Anderson Cancer Center), Isabelle Bedrosian(The University of Texas MD Anderson Cancer Center)Scientific ReportsJuly 22, 202210.1038/s41598-022-16779-yCited by 1SaveCiteExport RISWatch citationsRelated PapersResveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-κB–regulated antiapoptotic and cell survival gene products in human multiple myeloma cells|Blood|2006|392Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors|Cancer|2000|175Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer|Cancer Research|2023|15Supplementary Fig. S4 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer|Unknown|2023|0Figure 7 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer|Unknown|2023|0